Maryland House Bill HB1462

Maryland 2022 Regular Session

• Introduced: 2/25/22
• Refer: 2/25/22

Caption

Health - Ivermectin - Standing Order (Protocol Drug Act)

Impact

If passed, HB 1462 would fundamentally alter the interaction between healthcare practitioners and pharmacists in Maryland regarding ivermectin prescriptions. It establishes procedures such that pharmacists can dispense ivermectin based on a specified protocol included in the standing order. This is intended to ensure that patients can receive ivermectin in a manner that is legally recognized as appropriate for legitimate medical purposes in the ordinary course of practice.

Summary

House Bill 1462, titled 'Health - Ivermectin - Standing Order (Protocol Drug Act)', introduces a framework that allows licensed physicians and advanced practice registered nurses to prescribe ivermectin via a standing order. This bill aims to streamline the process through which pharmacists can dispense ivermectin, facilitating access to this medication without requiring a traditional prescription under certain conditions. The implementation of this bill is particularly significant given the heightened interest in ivermectin as a treatment option during the COVID-19 pandemic.

Contention

Notably, the bill aims to provide protections for healthcare providers by preventing disciplinary actions against physicians and nurses for pharmacists' failures to adhere to the standing order when the order meets stated requirements. This provision is intended to enhance the collaborative practice between disciplines while reducing liability concerns among providers. However, the bill may provoke debate regarding the appropriateness and effectiveness of ivermectin as a treatment for COVID-19, given mixed reviews from medical authorities about its efficacy.

Further_considerations

The legislation encourages the development of regulations to support its implementation, including the creation of standardized information for patients receiving ivermectin. Critics might raise concerns about the potential misuse of ivermectin or the risk of undermining the established medical guidelines, reflecting ongoing discussions in the healthcare community about treatment protocols during the pandemic.